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ABSTRACT
Earlier we have shown that exogenous expression
of HIPPI, a molecular partner of Huntingtin interact-
ing protein HIP-1, induces apoptosis and increases
expression of caspases-1, -8 and -10 in HeLa and
Neuro2A cells. The C-terminal pseudo death
effector domain of HIPPI (pDED-HIPPI) specifically
interacts with the putative promoter sequences of
these genes. In the present manuscript, we predict
from structural modeling of pDED-HIPPI that R393
of HIPPI is important for such interaction. R393E
mutation in pDED-HIPPI decreases the interaction
with the putative promoter of caspase-1 in cells.
Expression of caspase-1 is decreased in cells
expressing mutant pDED-HIPPI in comparison to
that observed in cells expressing wild type pDED-
HIPPI. Using HIP-1 knocked down cells as well as
over expressing HIP-1 with mutation at its nuclear
localization signal and other deletion mutations, we
demonstrate that translocation of HIPPI to the
nucleus is mediated by HIP-1 for the increased
expression of caspase-1. HIPPI-HIP-1 heterodimer
is detected in cytoplasm as well as in the nucleus
and is associated with transcription complex in
cells. Taking together, we are able to show the
importance of R393 of HIPPI and the role of HIPPI-
HIP-1 heterodimer in the transcription regulation
of caspase-1.
INTRODUCTION
HIPPI (HIP-1 protein interactor), also known as
ESRRBL1 (estrogen-related receptor beta like 1), a
homolog of Chlamydomonas intraﬂagellar transport 57
(IFT57), does not have any known domain except a
‘pseudo death eﬀector domain’ (pDED) and a myosin
like domain (MLD). Interaction of HIPPI with HIP-1 is
through the pDED, speciﬁcally through 409K, present
in the putative helix5 of HIPPI-pDED, although
other regions might have inﬂuence on such interactions
(1). HIPPI-HIP-1 heterodimer recruits procaspase-8
and activates the initiator caspase and its downstream
apoptotic cascades (1,2). It has been shown earlier that
the strength of interaction of HIP-1 with Huntingtin
(HTT) protein, whose mutation causes Huntington’s
disease (HD), is inversely correlated with the number of
glutamines (Q) at the N-terminal region of HTT (3). It is
proposed that weaker interaction of HIP-1 with mutated
HTT in HD might increase the freely available pool
of HIP-1 and might, in turn, enhance the propensity
of hetero-dimerization of HIP-1 with HIPPI. The
elevated pool of HIPPI-HIP-1 complex may then recruit
procaspase-8 and lead to increased cell death as observed
in HD (1,2).
In addition to increased apoptosis by the activation of
diﬀerent caspases, truncation of Bid, release of AIF from
the mitochondria, endogenous expressions of caspase-1,
-3, -7 and -8 are also increased in GFP-Hippi expressing
Neuro2A and HeLa cells, whereas mitochondrial genes
ND1, ND4 and anti-apoptotic gene Bcl-2 are down
regulated (2). We have subsequently shown that HIPPI
can directly interact both in vitro and in vivo with a
60bp sequence ( 151 to  92) upstream of the caspase-1
gene. HIPPI, especially its C-terminal pDED, interacts
with the speciﬁc sequence motif AAAGACATG ( 101
to  93) present at the promoter sequence of caspase-1
(4,5). Similar motifs are also present at the putative
promoter sequences of caspase-8 and caspase-10. HIPPI
interacts with these promoters and increases the expres-
sion of these genes (5). This result indicates that HIPPI,
without having any known DNA-binding domain,
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amino acid(s) that interact with the DNA sequence still
remains unknown. Besides, the question of nuclear
translocation of cytoplasmic HIPPI for transcription reg-
ulation, without having classical nuclear localization
signal (NLS) is yet to be resolved.
HIP-1, the molecular partner of HIPPI interacts with
membranes, traﬃcs endocytic vesicles and translocates
into the nucleus using its own NLS at the C-terminus (6)
and has been implicated in cancer (7). HIP-1 interacts
directly with androgen receptor (AR), accumulates in
the nucleus upon androgen stimulation and recruits to
DNA elements regulated by AR. AR also translocates
to the nucleus in response to androgen and the process
is facilitated by HIP-1 (6,8,9). HIP-1 thus regulates the
transcription of AR responsive genes through its interac-
tion with AR. Given that HIP-1 can act as the nuclear
transporter for AR and regulate the expressions of its
target genes, we tested the hypothesis that HIPPI might
also be translocated to the nucleus assisted by HIP-1 and
could regulate the expression of caspase-1 gene.
MATERIALS AND METHODS
Antibodies and other reagents
RNase A, BSA, Geniticin, Hygromycin, DAPI, Hoechst,
nuclei isolation kit, anti-Beta-actin (A2228, clone AC-74,
Lot number: 107K4791) antibody and Protein G were
obtained from Sigma Chemicals (MO, USA). Assay kit
for detection of caspase-8 activation was obtained from
Alexis Biochemicals, Switzerland. The anti-mouse and
anti-rabbit secondary antibodies conjugated with horse-
radish peroxidase, TRITC and FITC conjugated
antibodies were purchased from Bangalore Genei, India;
anti-GFP antibody was purchased from BD Biosciences,
USA (632375, Lot number: B7040316); anti-histone 2B
(H2B) antibody (IMG-359 Lot number: 073101A) and
anti-caspase-1 antibody (IMG-804-4, Lot number:
AB093004A) were from Imgenex, USA; anti-HIP-1 was
purchased from Novus Biologicals (NB300-204, 1B11,
Lot number: A); and anti-HIPPI antibody (ab5205-100,
Lot number: 63362) and anti-LaminB antibody
(ab16048-25, Lot Number 393854) were purchased from
Abcam, USA. Immobilon-P Transfer membrane was from
Millipore, USA, Chemilumiscence kit from Pierce, USA,
Taq polymerase from Bioline, USA, and restriction
enzymes (BamHI, SalI, SmaI, XhoI and HindIII) were
from Promega, USA. Protease inhibitor cocktail was
purchased from Roche, USA. Other molecular biology
grade ﬁne chemicals were procured locally.
Methods for modeling and prediction for DNA-binding
property
Comparative structure-based modeling was done using
MODELLER 8v1 (10) with a multiple structural
alignment template, generated by CEMC (11) using 3D
co-ordinates of all DED containing proteins (CATH
homologous super family 1.10.533.10) (12) from PDB
(13). Out of twenty energy-minimized models, one with
the minimum objective function was chosen for generating
accessible molecular surface with electrostatic potential
map using GRASP (14). Prediction of DNA-binding
property was made using PreDs, by submitting the
coordinates of modeled pDED of HIPPI and its mutant
protein via the online tool using default parameters
(http://pre-s.protein.osaka-u.ac.jp/ preds/). The tool
makes prediction of dsDNA-binding site on protein
surfaces. The prediction for the query protein is made
based on the value of the prediction score, Pscore, which
is a vectorial property of the surface and an indicator of
the ratio of the predicted area (Parea) to the whole area on
the protein surface. The protein with a higher Pscore than
0.12 is considered as a dsDNA-binding protein.
Construction of clones
Constructions of GFP-Hippi and GFP-pDED (coding for
335 to 429 amino acids of HIPPI) have been described
earlier (2,5). The HIP-1 clone in pcDNA3 (pcDNA3
Hip-1) was kindly provided by Prof. T.S Ross,
University of Michigan Medical School, USA. The
mutant HIP-1 containing a glutamic acid (E) at the
position 58 and 1005 (designated as Hip-1 58E and Hip-1
1005E) clones in pcDNA3 were kindly provided by Dr. Ian
Mills, CRUK Uro-Oncology Research Group,
Cambridge, CB2 0RE, UK. Full length Hip-1, N
terminus Hip-1 (Hip-1N, 1–258aa) and pDED of Hip-1
(Hip-1P, 410–491aa) were sub-cloned in DsRed C1
vector. The details of the primer sequence, PCR condition
and restriction enzymes used are shown in the Table 1.
Site directed mutagenesis
A mutation [replacing the Arginin (R) residue at 393
position of HIPPI (59th position of pDED of HIPPI),
by Aspartic acid (E) residue (AGA to GGA)] was
introduced in GFP-pDED of HIPPI by PCR directed
site-speciﬁc mutagenesis with GFP-pDED as a template.
The recombinant GFP-pDED was subjected to PCR-
directed mutagenesis using mutagenic oligonucleotide
primers containing mismatch bases. The mutagenic PCR
involved the generation of two PCR products that overlap
in sequence containing the same mutation introduced as
part of the PCR primers. A subsequent re-ampliﬁcation of
these fragments with cloning primers as described earlier
(5) resulted in the enrichment of the full-length pDED-
HIPPI.
MutR59EF: 50-GACATTgaAATTGGCATTGTGG-30
MutR59ER: 50-GCCAATTtcAATGTCCATCT-30
The mutation thus introduced was conﬁrmed by
sequencing. The plasmid harboring the mutated gene
was designated as GFP-mpDED.
Cell culture and transfection
HeLa and Neuro2A cells were routinely grown in MEM
(HIMEDIA, India) while K562 cells were grown in RPMI
(HIMEDIA, India) supplemented with 10% fetal bovine
serum (Biowest, USA) at 37 Ci n5 %C O 2 atmosphere
under humidiﬁed condition.
Transfection of cells was performed using
Lipofectamine 2000 (Invitrogen, USA). Unless otherwise
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plate) or 5mg (100mm plate) of DNA constructs as well as
7o r1 5 ml of Lipofectamine 2000 respectively were used.
For co-transfection, equal amount of DNA constructs
(5mg each for 100mm plate) were used. After 24h,
transiently transfected cells were checked for transfection
eﬃciency by monitoring GFP or DsRed expression under
ﬂuorescence microscope and were used for experiments.
Transfection eﬃciency varied from 70 to 90%.
To generate cell lines that stably express wild type and
mutant HIP-1, Neuro2A cells were grown in 100mm
plates to  30% conﬂuency. Cells were then transfected
using 5ml of Lipofectamine 2000 and 2mg of the
required plasmid [pcDNA3Hip-1, Hip-1 1005E, Hip-1
58E]. Transfected cells were then selected using G418
(ﬁnal concentration 0.4mg/ml). After 10–15 days, clones
were pooled and grown in the presence of G418. Before
the experiment selection was withdrawn and used for
the studies.
Knockdown of HIP-1 in HeLa and Neuro2A
cells by siRNA
DNA sequences 779-ACCGCTTCATGGAGCAGTTTA-
799 and 1394-ACAGCGATATAGCAAGCTAAA-1415
of human Hip-1 (gi|38045918|ref|NM_005338.4|) were
designed for the siRNAs using the online software from
GenScript (https://www.genscript.com/ssl-bin/app/rnai).
The scrambled sequence (50-TAGTCGCATACGGAAC
ATTCG-30) for the ﬁrst siRNA was also designed using
GenScript sequence scrambler tool. The complete
sequence which was inserted into the expression vector
pRNATin-H1.2/Hygro was 50-TAAACTGCTCCATGA
AGCGGTTTGATATCCGACCGCTTCATGGAGCAG
TTTATTTTTTCCAA-30 (designated Hip1Si) with termi-
nation signal and appropriate restriction site linkers
(BamH1 and HindIII, not shown) and an insert for loop
formation (underlined). Similarly for a second siRNA to
target the human Hip-1 the complete sequence 50-TTTAG
CTTGCTATATCGCTGTTTGATATCCGACAGCGA
TATAGCAAGCTAAATTTTTTCCAA-30 (designated as
Hip1Si1) was cloned as above. The entire sequence for the
scramble siRNA was 50-CGAATGTTCCGTATGCGA
CTATTGATATCCGTAGTCGCATACGGAACATTC
GTTTTTTCCAA-30 (designated as Hip1Scr). The cloned
fragments were sequenced and conﬁrmed. The cloned
DNA fragments (Hip1Si and Hip1Si1) were purchased
from GeneSript, USA and the Hip1Scr was cloned in
our laboratory using the restriction enzymes BamH1
and HindIII. The purchased clones were further checked
with the recommended restriction enzymes (BamH1
and HindIII) digestion and used for our experiments.
Mouse HIP-1 (gi|22122460|NM_146001) sequences
contain a single mismatch (410-ACCGCTTCATGGAG
CAGTTCA-430 of mouse HIP-1) compared with that of
in human (779-ACCGCTTCATGGAGCAGTTTA-799).
HIP-1 siRNA clones and the scramble siRNA were
transfected in HeLa cells using Lipofectamin2000
(Invitrogen, USA) using protocol provided by the manu-
facturer. Transfected cells were selected for Hygromycin
resistance. Colonies grown in presence of Hygromycin
were pooled and grown to suﬃcient numbers for protein
isolation and other experiments. Protein was isolated and
western blot analysis was carried out using anti HIP-1
antibody. Similarly for Neuro2A cells, Hip1Si was
transfected to knock down HIP-1. Similar down regula-
tion of HIP-1 was observed in spite of a single mismatch in
siRNA sequence. In parallel, HeLa cells were also
transfected with the empty vector (pRNATin-H1.2/
Hygro, without the insert) and selected for Hygromycin
resistance and used to check the expression of HIP-1. No
change in the expression of HIP-1 was observed with cells
expressing the empty vector. In all our experiments, we
have used HeLa cells or Neuro2A cells as the control,
while studying the eﬀect of HIP-1 (in knocked down cells).
Detection of apoptosis by nuclear fragmentation and
caspase-8 activation
Nuclear fragmentation and caspase-8 activation were
detected using the methods described earlier (2). In brief,
cells were grown on cover slips, washed thrice with PBS
and ﬁxed with 1:1 mixture of methanol and acetone (1h
at 4 C). Cells were then stained with 1mM Hoechst in
phosphate buﬀer saline (PBS) in the dark at room temper-
ature for 5min and observed under a ﬂuorescence micro-
scope (Olympus BX60 with appropriate attachment,
Japan). Cells with intact nuclear morphology (normal)
Table 1. Primer sequences for construction of various clones of Hip-1
Clone name Primer sequences Condition RE sites Host plasmid
DsRed-Hip-1 50-ACGCGTCGACCATGAGAAAGG-30 95 C!5min SalI DsRed-C1
50-AGGGGGCCCCGGTTACCACTT-30 [95 C3 0 s ,5 0  C3 0 s7 2  C 120s]
 32 cycles
SmaI
72 C!10min
DsRed-Hip-1N 50-CCGCTCGAGATGGATCGGATGGCCAGC-30 95 C!5min XhoI DsRed-C1
50-ACGCGTCGACCCCGGTGGCCTTGCAGGGTG-30 [95 C3 0 s ,5 5  C3 0 s ,7 2  C 120s]
 32 cycles
SalI
72 C!10min
DsRed-Hip-1P 50-ACGCGTCGACAGCGAGCTGGAAGCAGAT-30 95 C!5min SalI DsRed-C1
50-CGGGATCCCTCTGCATTCTTCCGCAGCA-30 [95 C3 0 s ,6 5  C3 0s ,7 2  C6 0 s ]
 35 cycles
BamH1
72 C!10min
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and the percentage of cells with apoptotic nuclei was
calculated. About 200–500 cells were counted for each
experiment. Activation of caspase-8 was determined
according to the protocols provided by the manufacturers
of the kit. Exponentially growing 2million HeLa cells
expressing GFP–wpDED and GFP-mpDED were col-
lected and processed as mentioned earlier (2). For the
caspase-8 detection, the ﬂuorescence of liberated AFC
was measured at its emission maxima (lmax 505nm) with
the excitation at the 400nm.
Confocal microscopy
Cells were grown on cover slips overnight and were
washed with PBS, ﬁxed with 1:1 mixture of methanol
and acetone, stained with 40,6-diamino-2-phenylindole
(DAPI; ﬁnal concentration 10mg/ml) and mounted on
clean glass slides using 1–2ml of glycerol. The cells were
visualized under confocal microscope (Zeiss LSM 510)
and the localization of GFP tagged and DsRed tagged
proteins were observed by exciting at 488 and 543nm,
respectively. Subsequent ﬂuorescence was monitored at
503nm and 583nm respectively using LSM 510 software.
Sub-cellular fractionation, immunoprecipitation and
western blot analysis
Cells grown in 100mm Petri dishes were washed with ice
cold PBS and harvested at 300g for 3min at 4 C. The
pellet was suspended in cytosol extraction buﬀer (50mM
Tris–Cl pH 7.5, 10mM NaCl, 2mM EDTA, 1mM PMSF
and 1  protease inhibitor cocktail) and kept on ice for
15–20min. Cells were then lysed by adding 0.25%
NP-40 and centrifuged immediately at 800g for 5min at
4 C. The supernatant was kept as cytosolic extract. The
pellet was then suspended in nuclear extraction buﬀer
(50mM Tris–Cl pH 7.5, 400mM NaCl, 2mM EDTA,
1mM PMSF and 1  protease inhibitor cocktail) and
kept on ice for 40min followed by centrifugation at
13000g for 20min at 4 C. The supernatant was kept as
nuclear extract. For immunoprecipitation assay with
cytosolic and nuclear extract, cytosolic extract was
prepared as described above. Nucleus was isolated by
resuspending the nuclear pellet in nuclear IP buﬀer
(50mM Tris–HCl pH 7.5, 150mM NaCl, 2mM EDTA,
1mM PMSF and 1  protease inhibitor cocktail) followed
by repeated freezing and thawing and centrifugation at
13000g for 20min at 4 C. The extracts are then incubated
with anti HIP-1 antibody (1:200 dilutions) for 2h at 4 C.
Next BSA soaked protein-G agarose was added to the
reaction mix and incubated over night at 4 C under con-
tinuous rotating condition. Next day the immunopre-
cipitated complex was collected by centrifugation at
1000g for 2min at 4 C. Beads were washed twice with
nuclear IP buﬀer, once with wash buﬀer I (50mM Tris–
Cl pH 7.5, 400mM NaCl, 2mM EDTA, 1mM PMSF and
1  protease inhibitor cocktail) and ﬁnally with wash
buﬀer II (50mM Tris–Cl pH 7.5, 400mM NaCl, 2mM
EDTA, 0.1% Triton X-100, 1mM PMSF and 1 
protease inhibitor cocktail). The bound proteins were
extracted from beads by boiling with SDS gel loading
buﬀer and were subjected to western blot using anti
HIPPI and anti HIP-1 antibody. The methods used for
western blot analysis was essentially the same as described
earlier (2).
For immunoprecipitation assay using whole cell extract,
cells grown in 10cm Petri dishes were washed in ice
cold PBS and harvested at 300g for 3min at 4 C. The
pellet was suspended in co-immunoprecipitation buﬀer
(50mM Tris–Cl pH 7.5, 15mM EDTA, 100mM NaCl,
0.1% Triton X-100 and PMSF with 100mg/ml ﬁnal
concentrations), lysed by freezing and thawing and
centrifuged at 13000g for 15min. The supernatant was
collected and protein was estimated. To detect GFP
tagged proteins, immunoprecipitation with anti-GFP
antibody (1:500 dilutions) was carried out using the
protocol described above. The beads were washed several
times with co-immunoprecipitation buﬀer and the
precipitated complex was extracted from beads by boiling
with SDS gel loading dye. Western blot analysis was per-
formed using anti-GFP, anti-caspase-8 and anti-HIP-1
antibodies. For other proteins, western blot analysis was
carried out using anti HIP-1; anti HIPPI, anti-GFP, anti-
H2B, anti Lamin B and anti Beta actin antibodies after
standardizing for appropriate dilutions. Beta actin was
used as internal control for cytoplasmic extract while
H2B or lamin B was used for loading controls for
proteins in the nuclear fractions. Each experiment was
repeated 2–3 times. Integrated optical density (IOD) of
each band was calculated using Image Master VDS
software (Amarsham Biosciences, UK). When ever neces-
sary, IOD was normalized with that of the loading control.
Immunocytochemistry
Cells were grown on cover slips and transfected with
respective constructs whenever necessary as described
above. Cells (after 24h of transfection, for transfected
cells) were ﬁxed with 3.7% freshly prepared
Paraformaldehyde for 20min at room temperature,
washed thrice with PBS, and permeabilized with 0.1%
Triton X-100 in PBS for 10min at room temperature. It
was then rinsed thrice with PBS and blocked in 2% BSA
for 1h. The coverslips containing cells were then
incubated for 1h at 37 C with primary antibodies (anti
HIP-1, anti HIPPI) with (1:50) dilutions. Cells were then
washed thrice with PBS and incubated with ﬂuorophore-
conjugated (FITC or TRITC) secondary antibodies at
37 C in dark. Cover slips were again washed with PBS
and then mounted on slides. Photographs were taken
using (ZEISS LSM 510) confocal microscope.
Chromatin immunoprecipitation (ChIP) and re-chromatin
immunoprecipitation (reChIP) assay
Methods used for the ChIP experiments were adapted
from the results published earlier (2). GFP-wpDED or
GFP-mpDED transfected HeLa cells and K562 were
grown on petri plates to 80–90% conﬂuency as mentioned
above. Cells were incubated with 2% formaldehyde for
2min at room temperature to cross-link the proteins
with the DNA. This cross-linking reaction was stopped
using 150mM Glycine. Cells were scraped and spun
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pellet was frozen in dry ice for 20mins. Buﬀer C (20mM
HEPES (pH 7.9), 25% glycerol, 420mM NaCl, 1.5mM
MgCl2, 0.2mM EDTA) with 1mM PMSF was added to
the pellet after thawing at 4 C to lyse the cells. Nuclei were
spun down at 15000g for 10min and the pellet was re-
suspended in breaking buﬀer (50mM Tris–HCl pH 8.0,
1mM EDTA, 150mM NaCl, 1% SDS and 2% Triton
X-100) and sonicated twice (two pulses of 10s each).
Contents were then spun down. The pellet was discarded.
Triton buﬀer (50mM Tris–HCl pH 8.0, 1mM EDTA,
150mM NaCl and 0.1% Triton X-100) was added to the
supernatant (nuclear extract). Anti-GFP (for GFP-pDED
transfected HeLa cells) or anti-HIPPI (for K562 cell)
antibody was added to a part of the nuclear extract
(+Ab) and antibody reaction was carried out overnight
at 4 C. Other part of the nuclear extract was kept at 4 C
( Ab). The next day Protein G Agarose beads were added
to the +Ab and  Ab fractions and left on a shaker for 6h
at 4 C. After 6h, beads were washed 4 times with Triton
buﬀer and two times with Tris buﬀer [10mM Tris–HCl
(pH 8.0)].
Next SDS–NaCl–DTT buﬀer (62.5mM Tris–HCl, pH
6.8, 200mM NaCl, 2% SDS 10mM DTT) was added to
the beads and incubated at 65 C overnight for reverse
cross-linking. Next day, all the fractions were subjected
to phenol chloroform extraction and the aqueous layer
was collected. Cross-linked DNA was precipitated with
3M Sodium acetate and ethanol. DNA pellet was
washed with 70% ethanol, dried and then dissolved in
distilled water. The DNA so obtained was ampliﬁed by
PCR using caspase-1 717bp upstream sequences (4). The
primer sequences (50–30) were as follows:
Forward: 50-GGAAGATCTGGCTTTTCTCTCTCCCTTC-30
Reverse: 50-CGGGGTACCAAGCCTAGGAAACACAAGGAGA-30
For re-ChIP assay, HeLa cells grown in 10cm Petri
dishes to  80–90% conﬂuency were transfected with
GFP-Hippi construct. After 24h, transfection eﬃciency
was monitored by ﬂuorescence microscopy and was
 80%. The cells were then cross-linked and the ﬁrst
immunoprecipitation using anti HIPPI antibody was
carried out as described above. The immunoprecipitated
chromatin was then eluted from beads using ChIP elution
buﬀer (50mM Tris–HCl, pH 7.5, 10mM EDTA, 1%
SDS) and incubating at 68 C for 10min. One part of the
eluted chromatin was subjected to reverse cross-linking
followed by phenol chloroform isolation of DNA as men-
tioned above to check the ﬁrst immunoprecipitation. The
other part of the eluted DNA-protein complexes was
diluted with Triton buﬀer and incubated with anti HIP-1
antibody over night at 4 C. Next day, the DNA-protein-
antibody complex was immunoprecipitated by adding
Protein G Agarose beads and DNA was extracted by
phenol chloroform isolation followed by ethanol precipi-
tation. PCR ampliﬁcation of the eluted DNA was carried
out using caspase-1 upstream (300bp) sequence speciﬁc
primers. The primer sequences (50–30) were as follows:
Forward: 50AATGATTGAGAAACTCTTCACTGTGT-30
Reverse: 50-CGGGGTACCAAGCCTAGGAAACACAAGGAGA-30
Real-time PCR
RNA (100ng) was reverse transcribed as described
earlier (2). Real-time RT–PCR reaction was carried out
using Sybr green 2  Universal PCR Master Mix (Applied
Biosystems, USA) in ABI Prism 7500 sequence detection
system. Each reaction was performed in triplicate using
primer sequences for caspase-1 (2). Non-template control
reaction at the same condition was performed to ascertain
the baseline and threshold value for the analysis. Ct
value obtained for caspase-1 was normalized with
respect to beta actin (Ct). Diﬀerences between the
Ct values of test and control sets were determined
(Ct). The fold change was determined using the
formula 2
–Ct.
Statistical analysis
All the experiments were done at least two times.
Statistical analysis, mainly unpaired t-test, whenever nec-
essary was carried out using the on-line software
GraphPad QuickCalc available at http//www.graphpad
.com/quickcalcs/ttest1.cfm
RESULTS
Modeling of pDED of HIPPI: possible residues involved
in the interaction with DNA
It has been shown earlier by us that pDED of HIPPI
(pDED-HIPPI) interacts with the putative promoter
sequence of caspase-1 (4,5). To interact with DNA,
pDED therefore requires a complimentary surface and
appropriate charge distribution on its interfaces. Amino
acid similarity of pDED-HIPPI with other DEDs (mainly
DNA-binding DED, known as DEDD) or any other
DNA-binding proteins did not provide any clue about
the surface charge property. Pseudo Death Eﬀector
Domains (pDED) of HIP-1 and HIPPI share 39.2% sim-
ilarity and 26.6% identity whereas pDED-HIPPI has
34.9% similarity and 21% identity with other DEDs (1).
To test the hypothesis that pDED-HIPPI might have
DNA-binding surface/groove, theoretical structural
model building for pDED was done using standard
procedures. The available surface of the model was
compared with the modeled structure of pDED of HIP-1
(pDED-HIP-1) (15) and the crystallographically deter-
mined (2.8A ˚ ) structure of DED of FADD (DED-
FADD) (16). Within the predictable limit of theoretical
model building and on the basis of the assumptions made
by Gervais and co workers (1) in deﬁning the pDED, the
modeled domain expectedly took up an orthogonal
six helix bundle conformation with rmsd (for Ca
superposition) values 1.26A ˚ and 0.9A ˚ for pDED-HIPPI
and pDED-HIP-1 respectively, despite a sequence homo-
logy of only  14% with their nearest neighbors. However,
only pDED-HIPPI showed a positively charged trough
on its surface (Figure 1B, shown in blue colour),
probably ﬁt for binding a linear stretch of DNA
molecule. In case of pDED-HIP-1 (Figure 1B), the
trough was only incompletely formed with partial charge
complimentarity. Generally, DED containing proteins do
882 Nucleic Acids Research, 2010,Vol. 38,No. 3not possess such a characteristic surface (Figure 1B, DED-
FADD) whereas DNA-binding DEDD proteins form
similar surface (17), with a few basic residues present at
the similar region in their primary structures (Figure 1A).
A closer look on wild type pDED-HIPPI model
[Figure 1C, wpDED (393R)] revealed that this surface
was constituted by helices a1, a3 and a4 and the surface
positive charge was contributed mainly by the side-chains
of R393, K384 and K382 of HIPPI residing on a4
(positions R59, K50 and K48 of pDED). We shall hence-
forth follow the amino acid numbering for the HIPPI only.
It was observed further that in silico mutation of R393 to
E393 destroyed the electrostatic surface that might help in
DNA recognition [Figure 1C, mpDED (393E)]. These
modeling studies indicated that mutation at any of these
residues on the DNA-binding interface formed by the
helices a1–a3–a4 might lead to the loss of putative
DNA-binding function of pDED-HIPPI.
We also used PreDs, a prediction tool for proteins to
bind with double stranded DNA (http://pre-s.protein
.osaka-u.ac.jp/ preds/), for checking the probable
ability of the wild type pDED-HIPPI (with R393) and
for its mutant form (with E393) to interact with DNA.
The score of this prediction (Pscore=0.13) was signiﬁcant
for the wild type pDED-HIPPI revealing that the wild
type domain may interact with DNA. The Pscore for the
mutant pDED-HIPPI was 0.05, indicating that the mutant
protein is unlikely to interact with DNA. Interestingly,
pDED-HIP-1 also provided an insigniﬁcant score
(Pscore=0.06) showing a lack of DNA-binding propen-
sity. PreDs prediction further supported this observation
in modeling studies described above.
Figure 1. Alignment of DED like domains of diﬀerent proteins and modeling of pDED of HIPPI and its mutant. (A) Amino acid sequence
alignment of DED like domains of HIP-1, HIPPI, DEDD, FLAME3, FADD and caspase-8A. N-terminal regions of the domains up to helix a5
are shown. Predicted helices are taken from published data (1). (B) Electrostatic surface potential of crystal structures of DED-FADD (PDB Id:
1a1w) and theoretical models of pDED-HIP-1 and pDED-HIPPI. Front view of the surface constituted by helices a1, a3, and a4 is shown. A
putative DNA-binding trough on pDED-HIPPI is marked by arrow (positive charge potential is shown in blue). Same region for pDED of HIP-1
formed partially complimentary surface for putative DNA-binding region whereas that of DED of FADD takes a diﬀerent topology with negatively
charged surface. (C) Model structures of wild type pDED of HIPPI with R393 and its mutant E393. In spite of having similar topology in both the
cases, they diﬀer in surface charge distribution.
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caspase-1 promoter and increase caspase-1 expression
We tested whether R393E mutation altered caspase-1
expression and DNA binding of pDED-HIPPI. We
cloned both wild type (R393) and mutated (E393)
pDED-HIPPI in pEGFP vector and expressed in HeLa
cells. These clones are denoted by wpDED and mpDED
respectively. Expressions of mpDED and wpDED were
similar as revealed by western blot analysis and confocal
microscopy (Figure 2A and B). Immunoprecipitation with
anti-GFP antibody and detection by anti-HIP-1 antibody
(Figure 2C, upper panel) revealed that both mutated and
wild type pDED interacted with endogenous HIP-1,
similar to that obtained with full length HIPPI (1,2).
We then tested whether mpDED altered the expression
of caspase-1 in comparison to that observed with wpDED.
Real time PCR using caspase-1 gene speciﬁc primers was
carried out using mRNA isolated from HeLa cells
expressing wpDED and mpDED. Results shown in
Figure 2F revealed that the mutation R393E signiﬁcantly
decreased the caspase-1 gene expression by about 22 fold
(n=3,P=0.001) in comparison to that obtained in cells
expressing wild type pDED-HIPPI. Unlike caspase-1
expression, nuclear fragmentation and caspase-8 activa-
tion were not decreased signiﬁcantly in mpDED cells in
comparison to that obtained with wpDED cells. Nuclear
fragmentation increased signiﬁcantly in GFP-wpDED
(P=0.0001, n=2) and GFP-mpDED (P=0.0016,
n=2) expressing cells in comparison to that obtained in
parental HeLa cells (Figure 2G). Similar signiﬁcant
increase in caspase-8 activation (P=0.0001, n=2) for
cells expressing wild type or mutated pDED-Hippi was
obtained. It is also to be noted that the ability of
pDED-HIPPI to induce nuclear fragmentation
(P=0.03, n=2) and caspase-8 activation (P=0.005,
n=2) were signiﬁcantly lower in comparison to that
obtained with full length HIPPI (comparing Figure 2G
and 3H). This data showed that the full length HIPPI
induced apoptosis more than that of pDED-HIPPI as
has already been shown earlier (1). Percent of cells con-
taining nuclear fragmentation in mpDED was (26±5)
whereas this value was (32±2) in wpDED cells
(Figure 2G). This diﬀerence was not statistically signiﬁ-
cant (P=0.14). Activation of caspase-8 (Figure 2G) was
also similar (P=0.2). These results showed that the
mutation R393E of pDED-HIPPI decreased the expres-
sion of caspase-1. However its ability to induce apoptosis
remains unaltered.
We then tested whether the mpDED could interact
with the caspase-1 promoter sequence in vivo as has been
shown with full-length HIPPI earlier by ChIP assay (4).
The result (Figure 2H) obtained in this experiment showed
that even though the wild type pDED was able to interact
with the caspase-1 upstream sequence (Figure 2H,
panel I), the mutant pDED was unable to do the same
(Figure 2H, panel II). It conﬁrmed our prediction from
the modeling study that the R393 of HIPPI was indeed
involved in the interaction with the caspase-1 promoter
sequence.
Role of HIP-1 in the increased expression of caspase-1
gene and apoptosis
In HeLa cells, considerable level of endogenous HIP-1 is
present without any detectable HIPPI expression (2). To
check whether HIP-1 played any role in enhanced expres-
sion of caspase-1, endogenous HIP-1 was knocked down
in HeLa cells by expressing speciﬁc siRNA cloned in
pRNA Tin-H1.2/Hygro (denoted by ‘Hip1Si’, see
‘Materials and Methods’ section for detail). To nullify
the possibility of any oﬀ target eﬀect of the siRNA, a
scramble siRNA (Hip1Scr) was also transfected in HeLa
cells. Stable transfections with the siRNA reduced the
expression of HIP-1. Result of a typical experiment is
shown in the Figure 3A and the average IOD of indepen-
dent experiments is shown in Figure 3B. Average expres-
sion of HIP-1 was reduced signiﬁcantly (P=0.0001,
n=5) to 0.37 in Hip1Si transfected cells compared to
that in HeLa cells (normalized IOD=1) while expression
of the scramble siRNA reduced the expression of HIP-1
slightly but was not statistically signiﬁcant (P=0.54,
n=3, Supplementary Figure S3).
To check further the speciﬁcity of HIP-1 down regula-
tion by the Hip1Si, we transiently transfected the wild type
Hip-1 cloned in pcDNA3 in stably transfected Hip1Si cells
(denoted by Hip1SiHip1 in Figure 3C). HIP-1 expression
in these cells was signiﬁcantly higher (P=0.013, n=3)
compared to the cells where HIP-1 was knocked down
(Figure 3C and 3D). This result shows that the Hip-1Si
speciﬁcally down regulates the expression of HIP-1.
To study the eﬀect of HIP-1 on caspase-1 expression,
we transiently transfected GFP-Hippi in HeLa as well as
in stably transfected Hip1Si cells (designated as ‘Hippi’
and ‘Hip1SiHi’ respectively) and compared the expression
of caspase-1 by western blot analysis (Figure 3E). It
was evident that caspase-1 expression was decreased
signiﬁcantly (n=3, P=0.0091) in ‘Hip1SiHi’ cells
compared to that observed in ‘Hippi’ cells. When GFP-
Hippi and pcDNA3 Hip-1 was transiently transfected in
cells stably expressing Hip1Si, the expression of HIP-1 was
lower than that of the parental HeLa cells, while higher
than Hip1Si cells. Such increase in HIP-1 expression in
HIP-1 knocked down cells also increased the expression
of caspase-1 (Figure 3E, middle panel and Figure 3G). As
described above, this result shows that the Hip1Si specif-
ically down regulates the expression of HIP-1 (Figure 3F)
and HIP-1 up regulates the expression of caspase-1.
Transient expression of GFP-Hippi in cells with
reduced HIP-1 ( 0.37 of the endogenous expression) sig-
niﬁcantly decreased nuclear fragmentation (P=0.0001)
and caspase-8 activation (P=0.0001) as shown in
Figure 3H. In summary, the above observations indicated
that HIP-1 is playing an important role in HIPPI mediated
transcription of caspase-1 and apoptosis induction by
HIPPI.
Translocation of HIPPI into the nucleus requires
expression of HIP-1
To investigate the role of HIP-1 on sub-cellular distribu-
tion of HIPPI, we transiently transfected GFP-Hippi in
HeLa and Hip1Si cells and visualized under confocal
884 Nucleic Acids Research, 2010,Vol. 38,No. 3Figure 2. Expressions of wild type and mutated GFP-pDED-HIPPI, their interactions with endogenous HIP-1 and inﬂuences on caspase-1 expres-
sion. (A) Western blot analysis with total cell extracts from parental HeLa cells (HeLa); wild type GFP-pDED expressing HeLa cells (wpDED) and
mutated GFP-(R393E) pDED expressing HeLa cells (mpDED) using anti GFP antibody. Upper panel represents the result of a typical experiment
for expression of exogenous GFP-wpDED and its mutant GFP-mpDED (39kDa). Lower panel represents 42kDa band corresponding to b-actin
used as loading control. (B) Confocal microscopic photographs showing the expression and cellular distribution of wild type GFP–pDED (upper
panel) and mutated GFP-pDED (E393) (lower panel) in HeLa cells. White bar represents the dimension of a single cell (50mm). (C) Western blot
analysis with immunoprecipitated protein pulled down by anti-GFP antibody from HeLa cells expressing GFP-wpDED (‘wpDED’), empty GFP
vector (‘GFP’) and GFP-mpDED (‘mpDED’). Upper panel: Lane +Ab represent immunoblot carried out using anti HIP-1 antibody with protein
immunoprecipitated by anti-GFP antibody; the band represents 120kDa HIP-1. Lane  Ab: Immunoprecipitation reaction is carried out similarly in
absence of GFP antibody. Lower panel: Same blot was stripped and immunobloted with anti-GFP antibody as control for immunoprecipitation
(25kDa band). (D) The bar diagram represents the mean integrated optical density IOD, (n=2) of bands obtained by western blot analysis with
anti-HIP-1 normalized by the IOD values obtained with anti-GFP antibody (speciﬁcation is shown in the Figure). Vertical bar represents the
standard deviation. (E) Western blot analysis of immunoprecipitated proteins by anti HIP-1 antibody from GFPwpDED and GFPmpDED cells
and detection of caspase-8 by anti caspase-8 antibody. Upper Panel: lane +Ab denotes immunoblot carried out with anti caspase-8 antibody from
immunoprecipitated proteins from cells mentioned above. Lane  Ab represents immunoprecipitation reaction in absence of anti HIP-1 antibody.
Lower panel represents immunobloting with anti HIP-1 antibody as control for immunoprecipitation. (F) Expression of caspase-1 in ‘mpDED’ and
‘wpDED’ cells by real time PCR using sequence speciﬁc caspase-1 primers. Expression of beta actin was taken as control. Signiﬁcance level is
P=0.001 (n=3). (G) Nuclear fragmentation (white bar) and caspase-8 activation (grey bars) in ‘mpDED’ and ‘wpDED’ cells. Signiﬁcance levels
(P-values) of diﬀerences in nuclear fragmentation and caspase-8 activation are 0.14 (*) and 0.2 (#) respectively. (H) In vivo interactions of wild type
pDED and mutated pDED with putative promoter sequence ( 700 to +17) of caspase-1 by ChIP assay. PCR ampliﬁcation was carried out using
caspase-1 upstream 717bp sequence speciﬁc primers from immuoprecipitated DNA pulled down by anti-GFP antibody from ‘wpDED’ (panel I) and
‘mpDED’ (panel II) cells. Lane M shows the markers, Lanes +Ab shows PCR ampliﬁcation of immunoprecipitated DNA by anti-GFP anibody,
lane  Ab represents PCR ampliﬁcation with chromatin prepared from the same cell extract using only Rabbit IgG secondary antibody but in
absence of anti-GFP antibody, Lane+shows PCR carried out with DNA isolated from HeLa cells, lane represents no template control for PCR.
Nucleic AcidsResearch, 2010, Vol.38,No. 3 885Figure 3. Role of endogenous HIP-1 in increased expression of caspase-1 gene and apoptosis induction by exogenous HIPPI. (A) Result of a typical
experiment to detect the endogenous expression of HIP-1 by western blot analysis (upper panel) in HeLa cells (designated as HeLa) and HeLa cells
stably transfected with Hip1Si construct to knock down HIP-1 (designated as ‘Hip1Si’), empty pRNATin-H1.2/Hygro vector (designated as vec) and
Hip1Si1 construct, siRNA to target a diﬀerent region of Hip-1 (designated as ‘Hip1Si1’). In the lower panel, the 42kDa band represents beta actin as
loading control. (B) The bar diagram represents mean integrated optical densities of bands corresponding to HIP-1 and normalized with that of the
loading control beta actin. In each case, the expression of HIP-1 in control HeLa cells was considered to be 1 and the relative expressions of the
experimental samples were determined. Level of signiﬁcance (P) for Hip1Si cells was P=0.0001 (n=4), for Hip1Si1 cells, P=0.0011 (n=3) and for
vector transfected cells P=0.25 (n=2) in comparison to that of HeLa cells. (C) Western blot analysis for the detection of HIP-1 (upper panel) in
parental HeLa cells (HeLa), HeLa cells transfected with Hip1Si construct (Hip1Si), HeLa cells transiently transfected with pcDNA3-Hip1
(HeLaHip1) and Hip1Si cells transiently transfected with pcDNA3-Hip1 (Hip1SiHip1). The lower panel represents 42kDa band of beta actin as
a loading control. (D) The bar diagram represents mean integrated optical densities of bands corresponding to HIP-1 and normalized with that of the
loading control beta actin. Level of signiﬁcances (P) are *P=0.0006,
#P=0.01,
$P=0.013. (E) Western blot analysis for the detection of HIP-1
(upper panel) and procaspase-1 (middle panel) in HeLa cells (‘HeLa’), HeLa cells transiently transfected with GFP-Hippi (‘Hippi’), Hip1Si cells
transiently transfected with GFP-Hippi (‘Hip1SiHi’) and Hip1Si cells transiently co-transfected with GFP-Hippi and pcDNA3-Hip-1
(‘Hip1SiHiHip1’). Lower panel shows the 42kDa band corresponding to loading control beta actin. (F) Bar diagram showing the mean IOD of
bands obtained by western blot analysis (n=3) with anti-HIP-1 antibody relative to the bands obtained for beta actin. Relative expressions of
experimental cases were determined by considering the expression in control HeLa cells to be 1. Level of signiﬁcances (P) are *P=0.0001,
#P=0.047. (G) Bar diagram showing the mean relative IOD (n=3) of bands obtained by western blot analysis with anti caspase-1 antibody,
normalized with that of loading control beta actin. Relative expressions of experimental cases were determined by considering the expression in
control HeLa cells to be 1. Levels of signiﬁcances between various pairs are indicated by diﬀerent symbols *P=0.0001,
#P=0.009,
$P=0.0045. (H)
Bar diagram showing caspase-8 activation by ﬂuoremetric assay (represented by white bars) and percentage of cells containing nuclear fragmentation
(grey bars) in ‘HeLa’, ‘Hip1Si’, ‘Hippi’ and ‘Hip1SiHi’ cells. Various symbols to indicate the paired samples compared are also shown in the ﬁgure.
The P values are *P=0.0001,
#P=0.0001.
886 Nucleic Acids Research, 2010,Vol. 38,No. 3microscope after 24h (Figure 4A). Result revealed that in
HeLa cells GFP-HIPPI was distributed through out the
cell whereas in Hip1Si cells, most of the GFP-HIPPI was
localized in the cytoplasm. Similar result was also
obtained by immunocytochemistry in Hip1Si cells using
anti-HIPPI antibody labeled with TRITC (Figure 4B).
We further compared the extent of HIPPI in the
cytoplasmic and nuclear fractions of the cell extract
from GFP-Hippi expressing HeLa cells (‘Hippi’) and
HeLa cells with knocked down HIP-1 (Hip1SiHi) using
western blot analysis. Result of a typical experiment is
shown in Figure 4C, panel I. The average IOD of two
independent experiments is shown graphically in the
panel II of Figure 4C. The result showed that nuclear
content of HIPPI in Hip1SiHi cells, where endogenous
HIP-1 had been knocked down, was reduced (27±3%)
compared to HeLa cells expressing GFP-HIPPI
(58±11%). The reduction was statistically signiﬁcant
(P=0.009). These results indicated that HIP-1 might be
involved in transporting its partner HIPPI from the cyto-
plasm to the nucleus.
We argued that if the endogenous HIP-1 was necessary
to translocate exogenous GFP-HIPPI into the nucleus, the
amount of HIP-1 should also increase in the nuclei of
GFP-Hippi expressing cells. Western blot analysis was
carried out to compare the amount of HIP-1 in the
nuclear and cytoplasmic fractions of HeLa cells expressing
GFP-Hippi (‘Hippi’) and the parental HeLa cells (HeLa).
Result of a typical experiment is shown in Figure 4D,
panel I. The average IOD of two independent experiments
graphically shown in Figure 4D, panel II, indicates that
the amount of HIP-1 in the nuclear fractions was
signiﬁcantly (P=0.04) increased in GFP-Hippi
expressing cells (46±6%) compared to that obtained in
HeLa cells (32±6%). This was further tested by
cytochemistry using either FITC (for endogenous HIP-1
detection in HeLa) or TRITC (for detection of
endogenous HIP-1 in presence of GFP-HIPPI) labeled
anti HIP-1 antibody (Figure 4E and F, respectively) in
HeLa and GFP-Hippi expressing HeLa cells. These
results showed that in the presence of GFP-HIPPI,
excess amount of endogenous HIP-1 could be detected
in the nucleus indicating that HIP-1 was translocated
into the nucleus together with HIPPI as shown in
Figure 4C. To investigate the role of diﬀerent domains
of HIP-1 in the translocation process of HIPPI, we
co-expressed GFP-Hippi along with full-length Hip-1,
Hip-1N-terminus (1–258 aa) and pDED of Hip-1
(410–491 aa) cloned in DsRed in HeLa cells and
observed under confocal microscope. It is to be noted
that neither of the fragments namely N-terminal and
pDED of HIP-1 contains the nuclear localization signals
(amino acid positions 996–1009) (6). When GFP-Hippi
was co-expressed with exogenous DsRed-Hip-1, the
proteins co-localize and are present through out the
cell (Supplementary Figure S1, panels I and IV). When
GFP-Hippi was co-transfected with DsRed-Hip-1N or
DsRed-Hip-1P, the nuclear localization of HIPPI was
reduced (Supplementary Figure S1, panels II and III).
However the extent of co-localization was much higher
in cells co-expressing GFP-Hippi and DsRed-Hip-1P
compared to GFP-Hippi and DsRed-Hip-1N (Supple-
mentary Figure S1, panels V and VI). This result was
similar to that published earlier showing HIPPI mainly
interacted with the pDED of HIP-1 (1). This result also
indicates that full length HIP-1 containing the nuclear
localization signal is possibly necessary to translocate
HIPPI into the nucleus.
HIPPI requires HIP-1 for nuclear translocation and
transcriptional regulation of caspase-1 in Neuro2A cells
We investigated the eﬀect of HIP-1 on the nuclear distri-
bution of endogenous HIPPI and its subsequent regula-
tion of caspase-1 expression, as described above with
HeLa cells. To exclude the possibility of any cell line
speciﬁc event related to the above observations, we ﬁrst
rechecked the role of HIP-1 in Neuro2A cells having
endogenous HIP-1 and HIPPI (2). We knocked down
endogenous HIP-1 in Neuro2A cells by Hip1Si (speciﬁc
siRNA designed for human Hip-1 gene, see ‘Materials
and Methods’ section). The human speciﬁc siRNA was
able to down regulate the mouse HIP-1 (Figure 5A,
designated as N2a Hip1Si). We further generated
Neuro2A cells stably expressing the exogenous wild type
Hip-1 (Figure 5A, denoted by N2aHip1), NLS mutant of
Hip-1 (R1005E, designated by N2a1005E) and lipid-
binding domain mutant of Hip-1 (K58E, designated by
N2a58E) cloned in pcDNA3 (see ‘Materials and
Methods’ section for details). Expression of endogenous
HIP-1, exogenous HIP-1 and the two mutants are shown
in Figure 5A, top panel. Average IOD of the protein
bands obtained in independent experiments are shown in
Figure 5B. Sub-cellular distribution of HIPPI in these cells
was determined by western blot analysis. Result showed
that proportion of nuclear HIPPI in the parental Neuro2A
cells (N2a) was (0.45±0.04) and reduced to (0.24±0.01)
in N2a Hip1Si cells. This decrease was statistically signif-
icant (P=0.02, n=2). Similarly, the cytoplasmic fraction
of endogenous HIPPI was increased signiﬁcantly in HIP-1
knocked down cells compared to that obtained in the
parental Neuro2A cells (Figure 5C and D). Exogenous
expression of wild type HIP-1 increased the nuclear
fractions of HIPPI slightly but the increase was not sta-
tistically signiﬁcant. However, exogenous expression of
the NLS mutant (1005E) of HIP-1 showed signiﬁcant
(P=0.0006, n=3) accumulation of HIPPI in the cyto-
plasm as expected (Figure 5E and F). In this case, the
nuclear fraction of HIPPI decreased from (0.47±0.015)
in N2a Hip1 cells to (0.31±0.04) in cells expressing NLS
mutant of HIP-1 (N2a1005E). Expression of Caspase-1 in
the above cells as revealed by western blot also correlated
with this observation. HIP-1 knocked down Neuro2A
cells showed signiﬁcantly (P=0.001, n=2) decreased
expression of caspase-1 (Figure 5G and H) while cells
over expressing wild type HIP-1 showed increase of the
same (P=0.0002, n=3). Moreover, caspase-1 expres-
sion was decreased signiﬁcantly (P=0.002, n=3)
in N2a1005E cells compared to the parental Neuro2A
cells. Caspase-1 expression in N2a 58E cells did not
change signiﬁcantly in comparison to that of Neuro2A
cells (P=0.13, n=2). This result shows that HIP-1,
Nucleic AcidsResearch, 2010, Vol.38,No. 3 887Figure 4. HIP-1 assists HIPPI for translocation into the nucleus from cytoplasm. (A) Representative photographs showing the localization of
exogenous GFP-HIPPI in HeLa cells (upper panel) and in ‘Hip1Si’ cells (lower panel) taken using confocal microscope. Nuclei were visualized
after staining cells with DAPI. White bar represents the dimension of a single cell (50mm). (B) Immunocytochemistry for detection of exogenous
GFP-HIPPI in HeLa and Hip1Si cells (HeLa cells stably transfected with HipSi, see text for details). HIPPI was immunostained with TRITC (Red)
labeled secondary antibody. Green ﬂuorescence signal of the GFP tag and red ﬂuorescence signal of TRITC co localized in HeLa (upper panel) and
in ‘Hip1Si’ (lower panel) (C) Western blot analysis for detection of cytoplasmic and nuclear fractions of GFP-HIPPI. HeLa cells expressing GFP-
HIPPI is designated as ‘Hippi’ and that of HIP-1 knocked down HeLa cells is designated as ‘Hip1SiHi’. Panel I: Upper panel shows the distribution
of 74kDa band corresponding to GFP–HIPPI in nuclear and cytoplasmic fractions of ‘Hippi’ and ‘Hip1SiHi’ cells. Middle panel shows the 42kDa
band corresponding to beta actin protein used as loading control for cytoplasmic extracts. Lowermost panels represent the 15kDa band corre-
sponding to H2B used as loading control for nuclear extract. Panel II: Bar diagrams showing fractions of GFP-HIPPI (expressed as percentage) in
the cytoplasm (white bars) and nucleus (grey bars) obtained in 3 independent experiments using GFP-Hippi expressing HeLa cells (Hippi) and HIP-1
knocked down cells (Hip1SiHi). IODs obtained in each fraction were normalized by the IOD values obtained with anti beta actin (cytoplasmic) or
H2B (nuclear) antibodies. Proportion of proteins in the cytoplasm and nucleus was determined by dividing the corresponding normalized IOD in
cytoplasm and nucleus with the total IOD in the two compartments. The P-value indicates signiﬁcant diﬀerence of GFP-HIPPI localization in nuclei
of ‘Hippi’ and ‘Hip1SiHi’ cells. (D) Western blot analysis for the detection of cytoplasmic and nuclear fractions of endogenous HIP-1 in ‘Hippi’ and
‘HeLa’ cells. Panel I: Upper panel represents the 120kDa band corresponding to HIP-1 protein present in nuclear and cytoplasmic fractions of
‘Hippi’ and parental HeLa cells. Middle panel shows the 42kDa band corresponding to beta actin used as loading control for cytoplasmic extracts.
Lowermost panels represent the 15kDa band corresponding to H2B used as loading control for nuclear extract. Panel II: Histograms showing
average (n=3) of relative IOD (expressed as percentage) of bands obtained by western blot analysis with anti HIP-1 antibody determined as
described in (C) above. Level of signiﬁcance (*P=0.04, n=3) is also shown in the ﬁgure. (E) Immunocytochemistry for the localization of
endogenous HIP-1 in HeLa cells using anti HIP-1 antibody labeled with FITC (green). (F) Immunocytochemistry showing co-localization of
GFP-HIPPI with endogenous TRITC labeled HIP-1 in GFP-Hippi transfected HeLa cells.
888 Nucleic Acids Research, 2010,Vol. 38,No. 3Figure 5. Involvement of HIP-1 and its mutants in transport of HIPPI into the nucleus and alteration of caspase-1 expression in Neuro2A cells.
(A) Western blot analysis with total cell extracts from Neuro2A cells (‘N2a’), HIP-1 knocked down Neuro2A cells (‘N2a Hip1Si’) and Neuro2A cells
over expressing wild type pcDNA3-Hip-1 (‘N2a Hip1’), NLS mutant (‘N2a 1005E’) and lipid-binding domain mutant of Hip-1 (‘N2a 58E’). Both the
NLS mutant and the lipid-binding domain mutant are cloned in pcDNA3. Upper panel shows the band corresponding to 120kDa HIP-1. Lower
panel shows the 42kDa band of beta actin (B-actin) as loading control. (B) The bar diagram represents the mean IOD (n=2) of bands obtained by
western blot analysis with anti HIP-1 antibody and normalized by the IOD values obtained with anti beta actin antibody. Level of signiﬁcance are
*P=0.002,
#P=0.001,
$P=0.04,
%P=0.03. (C) Western blot analysis for cytoplasmic (Cy) and nuclear (Nu) protein fractions of ‘N2a’ and ‘N2a-
Hip1Si’ cells. Upper panel shows the 49kDa band corresponding to endogenous HIPPI. Lower panel represents the 15kDa band of H2B as loading
control for nuclear proteins. (D) Histogram representing the average (n=2) of normalized IOD of bands corresponding to nuclear (grey bars) and
cytoplasmic (white bars) fractions of HIPPI. Proportions of HIPPI in diﬀerent cellular compartments were determined as described in the legend 4C.
Level of signiﬁcance is *P=0.02. (E) Western blot analysis for detection of cytoplasmic and nuclear fractions of HIPPI in the parental Neuro2A
cells (N2a), Neuro2A cells stably transfected with pcDNA3-Hip-1 (N2aHip1) and Neuro2A cells stably transfected with pcDNA3-Hip-1 with
mutation at the NLS (N2a1005E). Upper panel shows the 49kDa band corresponding to endogenous HIPPI. Middle panel indicates cytoplasmic
loading control beta actin (42kDa). Lower panel indicates the 66kDa band of Lamin B as loading control for nuclear protein. (F) Bar diagram
showing the average (n=3) fractions of endogenous HIPPI in the cytoplasm and nucleus in diﬀerent cells as described in the legend of (E) above.
Proportions of HIPPI were calculated as described in the legend of Figure 4C. Level of signiﬁcance (*P=0.0006) is also shown in the ﬁgure. (G)
Eﬀect of HIP-1 and its mutants on the caspase-1 expressions in the parental Neuro2A cells (N2a), Neuro2A cells expressing stably Hip1Si
(N2aHip1Si), wild type Hip-1 cloned in pcDNA3 (N2aHip1), pcDNA3-Hip-1 with mutations in lipid-binding domain (N2a58E) and NLS
(N2a1005E). In the upper panel the 45kDa bands correspond to pro-caspase-1. Lower panel shows the loading control beta actin (42kDa). (H)
The bar diagram shows the mean (n=3) relative expression of caspase-1 in indiﬀerent cells described in G above. IOD value of the caspas-1 speciﬁc
band of the parental Neuro2A cells was normalized with the loading control beta actin and was considered to be 1. *P=0.0027,
#P=0.0002,
$P=0.002.
Nucleic AcidsResearch, 2010, Vol.38,No. 3 889speciﬁcally the NLS of HIP-1 is necessary to translocate
HIPPI into the nucleus and regulate the expression of
caspase-1.
Similar to what have been shown in HeLa cells
with knocked down HIP-1, cytochemistry of endogenous
HIPPI in HIP-1 knocked down Neuro2A cells revealed
that presence of endogenous HIPPI in nucleus was
also reduced compared to parental Neuro2A cells
(Figure S2).
In vivo interaction of HIP-1-HIPPI heterodimer with
caspase-1 promoter
To address whether HIPPI-HIP-1 heterodimer was
present in the nucleus, Neuro2A cells were fractionated
and subjected to immunoprecipitation using anti HIP-1
antibody. Western blot analysis using anti-HIPPI
antibody showed that HIPPI was co-immunoprecipitated
with HIP-1 from both cytoplasmic and nuclear fractions
indicating the presence of the heterodimer in both the
compartments (Figure 6A). To test if endogenous HIPPI
interacted with the caspase-1 promoter in vivo, we have
used K562 cells where both HIPPI as well as HIP-1
were substantially expressed as opposed to HeLa where
the expression of endogenous HIPPI was lacking (2).
Chromatin immunoprecipitation with anti HIPPI
antibody and detection of the promoter sequence of
caspase-1 by promoter-speciﬁc PCR primers indicated
that endogenous HIPPI could interact with the caspase-1
promoter sequence (Figure 6B). Further, to check the
association of HIP-1 with the caspase-1 promoter as a
part of transcription complex with HIPPI, re-ChIP exper-
iment was performed. GFP-Hippi expressing HeLa
cells were subjected to chromatin immunoprecipitation
with anti HIPPI antibody and the immunoprecipitated
complex was further subjected to re-ChIP using anti
HIP-1 antibody. The precipitated DNA was PCR
ampliﬁed using sequence speciﬁc primers for caspase-1
promoter. As revealed from Figure 6C, HIP-1 was also
found to be associated with caspase-1 promoter as a
part of HIPPI-HIP-1 complex. Taking together, the
results indicated that HIPPI-HIP-1 heterodimer could
interact with the promoter of caspase-1in vivo.
DISCUSSION
To identify the speciﬁc amino acid of HIPPI that interacts
with caspase-1 promoter sequence, we hypothesized on the
basis of structural modeling of pDED-HIPPI that R393 of
HIPPI residing at putative a4 helix of pDED-HIPPI might
be involved in such interaction and tested the hypothesis.
We also determined the role of HIP-1, the molecular
partner of HIPPI, in the translocation of HIPPI into the
nucleus, in a similar way to that has been observed for AR
(6). Results presented in this manuscript showed that
R393 of HIPPI was involved in its interaction with
caspase-1 promoter sequence in cultured cells and
regulated the transcription of caspase-1 gene. Mutant
pDED-HIPPI was able to interact with HIP-1 and
activated Caspase-8. Besides, HIP-1 was involved in
translocation of HIPPI from cytoplasm to the nucleus.
Finally, we show that HIPPI-HIP-1 heterodimer
participates in the transcription regulation of caspase-1
gene.
Death eﬀecter domain (DED) containing proteins are
known to participate in diverse cellular functions
including apoptosis through receptor signalling (18,19).
Other DED containing proteins namely, DEDD has
been reported to regulate the transcription by RNA
polymerase I (20,21). We have shown earlier that the
expression of caspase-1 gene is increased in GFP-Hippi
Figure 6. Interaction of HIPPI with HIP-1 in cytoplasm and nucleus
and subsequent interaction of the complex with caspase-1 promoter
in vivo. (A) Interaction of HIP-1 with HIPPI in cytoplasm and
nucleus. Cytoplasmic (denoted by Cy) and nuclear (denoted by Nu)
fractions of the cell extract were separately immunoprecipitated with
anti HIP-1 antibody, transferred to membrane and detected with anti
HIPPI antibody. Upper panel shows the bands corresponding to the
endogenous HIPPI (49kDa), while the lower panel represents the HIP-
1 (120kDa). Lanes indicated as +Ab show the result when the cell
extracts were treated with anti HIP-1 antibody while  Ab lanes show
the result without anti HIP-1 anti body (only IgG). (B) In vivo
interactions of endogenous HIPPI with the caspase-1 putative
promoter sequences in ChIP assay with K562 cells. PCR ampliﬁcation
was carried out using caspase-1 upstream 717bp ( 700 to +17)
sequence speciﬁc primers from immuoprecipitated DNA-protein
complex using anti-HIPPI antibody. Lanes +Ab: PCR was carried
out with immunoprecipitated DNA-protein complex using anti-HIPPI
antibody. PCR was also carried out with chromatin prepared from the
same cell extract using only Rabbit IgG secondary antibody but in
absence of anti HIPPI antibody (lane:  Ab). Lane In shows the
result when PCR was carried out with DNA isolated from K562
cells. Lane  ve shows the result when PCR was carried out where
no template was added. (C) In vivo interactions of HIP-1 with
caspase-1 putative promoter sequence by re-ChIP assay in HeLa cells
expressing GFP-Hippi. Precipitated chromatin is PCR ampliﬁed using
caspase-1 promoter 300bp ( 283 to +17) speciﬁc primers. Lane +Ab
‘HIPPI’: PCR ampliﬁcation was carried out using chromatin
immunoprecipitated by anti HIPPI antibody. Lane +Ab ‘HIP1’:
PCR ampliﬁcation was carried out using chromatin re-immunoprecipi-
tated by anti HIP-1 antibody. Lane  Ab: PCR ampliﬁcation was
carried out using chromatin immunoprecipitated by IgG alone. Lane
In: PCR ampliﬁcation was carried out using DNA isolated from GFP-
Hippi expressing HeLa cells. Lane +ve: PCR ampliﬁcation was carried
out using a deﬁnite template of Caspase-1 promoter. Lane  ve: PCR
ampliﬁcation was carried out without adding any template.
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interacts with the putative promoter of caspase-1, espe-
cially to the motif 50-AAAGACATG-30 ( 101 to  93)
present at the promoter sequence of caspase-1. HIPPI
also binds to the putative promoter sequences of
caspase-8 and caspase-10 where similar motifs are
present (2,4,5). Our modelling studies revealed that the
mutation R393E alters the local surface as well as
the charge distribution but the overall conformation of
the domain remains unperturbed (RMSD of R393 and
E393 for Ca superposition=0.024A ) (Figure 1). We fur-
ther showed experimentally that the mutation of R393E
of pDED-HIPPI decreased caspase-1 expression
(Figure 2F) and abolished/decreased the binding of
pDED-HIPPI to caspase-1 promoter in HeLa cells
(Figures 2H). It has been shown earlier that K409 at the
helix 5 of pDED-HIPPI is required for its interaction with
HIP-1 and apoptosis induction (1), while we showed that
the putative a4 helix of pDED of HIPPI was involved in
the transcription regulation. Mutation R393E did neither
alter the ability to interact with the endogenous HIP-1
(Figures 2C) nor the ability to activate caspase-8 and
apoptosis (Figure 2G). HIPPI has been shown to induce
apoptosis in co-operation with HIP-1 (1). Contradictory
ﬁndings that HIP-1 may act as a prosurvival/antiapoptotic
(22–25) or proapoptotic protein (1,2,26,27) depending on
its interaction with other partner and reviewed recently
(28). Our result shows the involvement of the speciﬁc
amino acid R393 of HIPP1 for its interaction with
speciﬁc DNA sequence and transcription regulation of
caspase-1. However, mutation R393E of p DED-HIPPI
did neither alter its ability to interact with HIP-1 nor
apoptosis induction. The ability to regulate the transcrip-
tion of caspase-1 and apoptosis by HIPPI thus resides in
two diﬀerent locations namely at a5 helix and a4 helix of
pDED-HIPPI.
HIP-1 has recently been shown to enhance the tran-
scription of AR-responsive genes by translocating AR to
the nucleus in response to androgen. Furthermore, HIP-1
also acts as a co-activator for estrogen and glucocorticoid
receptors. HIP-1 harbours NLS at its C-terminal (amino
acid positions 996–1009) and a point mutation (R1005E)
resulting in reduction of nuclear localization. HIP-1 is also
known to reduce the rate of degradation of AR (6). Initial
indirect evidence that similar mechanism is also involved
in caspase-1 regulation by HIPPI has been provided
earlier. Involvement of HIP-1 in the expression of
caspase-1 is inferred indirectly from the result obtained
in cells co-expressing HTT exon1, containing 16 CAG
repeats tagged with DsRed, together with GFP-Hippi in
HeLa cells. Over expression of N-terminal HTT with 16Q
(coded by exon-1 of HTT) decreases the expression of
caspase-1 in comparison to that obtained in HeLa cells
expressing GFP-Hippi only (28). It has been argued that
in presence of excess wild type HTT, endogenous HIP-1
preferentially interacts with it, decreasing freely available
HIP-1 and thus also the availability of HIPPI-HIP-1
heterodimer (1,2). In turn this might lead to less HIPPI
in the nucleus and reduces the expression of caspase-1
(2,28). Several lines of evidences provided in this
manuscript further showed that full length HIP-1 is
necessary for the relocation of cytoplasmic HIPPI into
the nucleus. First, in the presence of exogenous HIPPI
and endogenous HIP-1 in HeLa cells, the extent of
nuclear fractions of HIPPI as well as HIP-1 was increased
signiﬁcantly (Figure 4D) and the expression of caspase-1
was also elevated under such condition (2). Secondly, in
HeLa cells with knocked down HIP-1, the extents of
nuclear fraction of exogenous HIPPI as well as the expres-
sion of caspase-1 were decreased (Figures 4A, B, C, and
3A). Similar result was also obtained with pDED of
HIPPI (data not shown). Thirdly, knocked down
endogenous HIP-1 in Neuro2A cells decreased the extent
of nuclear fractions of endogenous HIPPI (Figure 5C and
D) and in such condition the expression of caspase-1 was
reduced (Figure 5G and H). Finally, exogenous expres-
sion of HIP-1 signiﬁcantly increased the expression of
caspase-1. The exogenous expression of NLS mutant of
HIP-1 resulted in cytoplasmic accumulation of HIPPI
thereby decreasing expression of caspase-1. In the
presence of exogenous mutant HIP-1, possibly some
fractions of endogenous HIPPI remained in the cytoplasm
by interacting with mutant HIP-1 and thus reduced the
caspase-1 expression. Role of endogenous HIPPI in the
regulation of caspase-1 expression was evident from
the HIP-1 knocked down cells where nuclear fraction of
endogenous HIPPI was reduced. As expected in such con-
dition, the expression of caspase-1 was also reduced. In
addition, using K562 cells, where endogenous HIP-1 and
HIPPI were present, we observed that HIPPI could bind
to the caspase-1 promoter in vivo (Figure 6B).
To identify whether HIPPI-HIP-1 heterodimer directly
interacts with DNA, we ﬁrst observed that HIPPI-HIP-1
complex was present in cytoplasm as well as in the
nucleus (Figure 6A). In re-ChIP assay using GFP-Hippi
expressing HeLa cells where anti HIPPI antibody was
used initially to pull down DNA-protein complex and
then the immunoprecipitated complex was further pulled
down by anti HIP-1 antibody, we could detect caspase-1
upstream sequence (Figure 6C). This result showed that
HIPPI-HIP-1 was present in the transcription complex.
We have earlier shown that RNA polymerase II is also
present in the HIPPI-DNA complex (4). Taking together,
this result showed that HIPPI-HIP-1 interacted with the
promoter of caspase-1 and formed active transcriptional
complex. It remains to be found out whether HIP-1 also
directly interacts with DNA. Role of other interacting
partners of HIPPI, namely RYBP (29) and BAR (30) in
the transcription regulation by HIPPI is also elusive.
In summary, we showed that R393 of HIPPI at the a4
helix of pDED-HIPPI was involved in the interaction with
DNA (this study) and a diﬀerent interface formed by the
amino acids at helix a5 participated in the interaction of
pDED-HIPPI with HIP-1 and apoptosis regulation (1).
We provided a second example (other than AR), where
HIP-1, an endocytic protein is involved in a nuclear
function. Signiﬁcance of this result in connection with
Huntington’s disease is not known at present. However,
result presented in this communication together with our
earlier published work (2,4,5,28) established HIPPI as a
transcription regulator for caspase-1 gene. It would be
of immense interest to ﬁnd out other genes, including
Nucleic AcidsResearch, 2010, Vol.38,No. 3 891those altered in Huntington’s disease that may be
regulated by HIPPI.
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